lobbying_activities: 987927

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
987927	2330c816-9c47-495a-bd8f-a641c3cc7bae	Q3	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2010	third_quarter	PHA	Communications with Food and Drug Admnistration on Risk Evaluation and Mitigation Strategies, reauthorization of the Prescription Drug User Fee Act, medical product recalls, experimental study of patient information prototypes and patient medication information, drug shortages, and generic drug user fees. Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. HR 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions.	Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		250000	0	0	2010-10-05T15:34:29.837000-04:00